BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21152045)

  • 21. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
    Kinney GG; Burno M; Campbell UC; Hernandez LM; Rodriguez D; Bristow LJ; Conn PJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):116-23. PubMed ID: 12660307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for mGluR5 receptors in intravenous methamphetamine self-administration.
    Osborne MP; Olive MF
    Ann N Y Acad Sci; 2008 Oct; 1139():206-11. PubMed ID: 18991866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice.
    Ward SJ; Walker EA
    Behav Pharmacol; 2009 Oct; 20(7):605-13. PubMed ID: 19745722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism.
    Cowen MS; Krstew E; Lawrence AJ
    Psychopharmacology (Berl); 2007 Jan; 190(1):21-9. PubMed ID: 17096086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mGlu5 receptor deletion reduces relapse to food-seeking and prevents the anti-relapse effects of mGlu5 receptor blockade in mice.
    Eiler WJ; Baez M; Yu J; Witkin JM
    Life Sci; 2011 Dec; 89(23-24):862-7. PubMed ID: 21983299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
    Paterson NE; Semenova S; Gasparini F; Markou A
    Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
    Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escalation of food-maintained responding and sensitivity to the locomotor stimulant effects of cocaine in mice.
    Goeders JE; Murnane KS; Banks ML; Fantegrossi WE
    Pharmacol Biochem Behav; 2009 Jul; 93(1):67-74. PubMed ID: 19376153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
    Koeltzow TE; Vezina P
    Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
    Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mGluR5 in cortical excitatory neurons exerts both cell-autonomous and -nonautonomous influences on cortical somatosensory circuit formation.
    Ballester-Rosado CJ; Albright MJ; Wu CS; Liao CC; Zhu J; Xu J; Lee LJ; Lu HC
    J Neurosci; 2010 Dec; 30(50):16896-909. PubMed ID: 21159961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice.
    Aguilar DD; Strecker RE; Basheer R; McNally JM
    J Neurophysiol; 2020 Jan; 123(1):22-33. PubMed ID: 31747354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking.
    Bäckström P; Hyytiä P
    Neuropsychopharmacology; 2006 Apr; 31(4):778-86. PubMed ID: 16123768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mGlu5 receptor antagonist MTEP attenuates opiate self-administration and cue-induced opiate-seeking behaviour in mice.
    Brown RM; Stagnitti MR; Duncan JR; Lawrence AJ
    Drug Alcohol Depend; 2012 Jun; 123(1-3):264-8. PubMed ID: 22129842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabotropic glutamate receptor 5 (mGluR5) regulates proliferation and differentiation of neuronal progenitors in the developmental hippocampus.
    Xiao XL; Ma DL; Wu J; Tang FR
    Brain Res; 2013 Feb; 1493():1-12. PubMed ID: 23165119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors.
    Ripley TL; Gadd CA; De Felipe C; Hunt SP; Stephens DN
    Neuropharmacology; 2002 Dec; 43(8):1258-68. PubMed ID: 12527475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice.
    Risinger FO; Freeman PA; Rubinstein M; Low MJ; Grandy DK
    Psychopharmacology (Berl); 2000 Oct; 152(3):343-50. PubMed ID: 11105945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.
    Mcgeehan AJ; Janak PH; Olive MF
    Psychopharmacology (Berl); 2004 Jul; 174(2):266-73. PubMed ID: 14726993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
    Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
    Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.